Stock photo of a strain similar to Curaleaf® T20 Royal Moby
Curaleaf® T20 Royal Moby
Medical
Hybrid
THC 20%
CBD 1%
.png)
Terpenes
Dominant
Other
Myrcene (herbal), Limonene (citrus), Caryophyllene (pepper)
Genetics
Parents: Haze x White Widow
Curaleaf® T20 Royal Moby Medical Cannabis Flower is an impressive hybrid weed strain with parent genetics from Haze and White Widow. Despite its low THC percentage of 20% and a CBD percentage of 1%, this cannabis strain provides an uplifting and focused feeling, making it perfect for those struggling with chronic pain, depression, or stress. Its unique flavour profile combines citrus, earthy, and pine notes, primarily dominated by the terpene Beta-Pinene, and complemented by Myrcene, Limonene, and Caryophyllene. This makes Royal Moby a top choice for those seeking relief with a euphoric edge.
Curaleaf® T20 Royal Moby Strain Reviews
4.0
1 reviews
Lozza
Great for mornings
4 out of 5 stars
I quite like this for the morning and early afternoon as it controls pain and gives me energy
.png)
Strains related to Curaleaf® T20 Royal Moby
Medical
Indica
THC 18%
CBD 1%
Clearleaf® GOZ T21 Gorilla Zkittlez
No reviews yet
Helps With: Chronic pain, Stress, Depression
Medical
Hybrid
THC 17%
CBD 1%
Breathing Green GOG T23 Glueberry OG
No reviews yet
Helps With: Chronic pain, Inflammation, Stress, Depression
Medical
Indica
THC 20%
CBD 1%
Curaleaf® GG4 T23 Gorilla Glue #4
2
Helps With: Chronic pain, Stress, Depression
Medical
Indica
THC 25%
CBD 1%
Big Narstie Medical T26 Moroccan Peaches
No reviews yet
Helps With: Chronic pain, Stress, Anxiety, Depression
*Statements made on this website have not been evaluated by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). These products are not intended to diagnose, treat, cure, or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.
**Consumers have reported these possible side effects. However it is important to note that cannabis affects everybody differently, and a majority of consumers report not experiencing side effects when consuming cannabis.